Admittedly, it has been a while since Bionano Genomics (NASDAQ:BNGO) stock has been a “hot stock,” a “meme stock” or whatever you want to call it. Since its big drop in late February and early March, the market has had mixed feelings about this life sciences company.
Similarly, Who owns Bionano genomics?
Top 10 Owners of Bionano Genomics Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 5.74% | 16,609,007 |
| The Vanguard Group, Inc. | 4.86% | 14,064,639 |
| SSgA Funds Management, Inc. | 2.49% | 7,198,880 |
| Geode Capital Management LLC | 1.63% | 4,714,883 |
Does Cathie own BNGO? Is Cathie Wood Invested in BNGO? As of the time of this writing, it does not appear that Cathie Wood or ARK are invested in Bionano Genomics. The firm’s genomics and biomedical ETF, ARKG, currently contains 52 individual holdings.
Thereof, Should I invest in BNGO stock?
The financial health and growth prospects of BNGO, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of F.
What institutions are buying BNGO?
Bionano Genomics (NASDAQ:BNGO) Institutional Buying and Selling
| Reporting Date | Hedge Fund | Ownership in Company |
|---|---|---|
| 2/14/2022 | Nuveen Asset Management LLC | 0.357% |
| 2/14/2022 | Barclays PLC | 0.123% |
| 2/14/2022 | GSA Capital Partners LLP | 0.019% |
| 2/14/2022 | Mutual Advisors LLC | 0.017% |
Is BNGO an American company?
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. … The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
How many shares are there of BNGO?
BioNano Genomics Inc (US:BNGO) has 292 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,218,166 shares.
What sector is BNGO in?
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space.
Is BNGO in ARKG?
Ark Invest’s Chapter in the BNGO Stock Story
The fund manager has sent some public praise BNGO’s way. Ark even has a special portfolio — Ark Genomic Revolution ETF (NYSEARCA:ARKG) — for just that sort of stock material. Thus, it was only a matter of time before the stock caught on, right?
What does Bionano genomics do?
Bionano Genomics, Inc. provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents.
Did BlackRock buy BNGO stock?
ownership in BNGO / BioNano Genomics Inc – 13F, 13D, 13G Filings – Fintel.io.
…
BlackRock Inc. ownership in BNGO / BioNano Genomics Inc.
| Security | BNGO / BioNano Genomics Inc |
|---|---|
| Institution | BlackRock Inc. |
| Latest Disclosed Ownership | 18,660,129 shares |
| Ownership | 6.50% |
Who owns NNDM stock?
Largest shareholders include ARK Investment Management LLC, ARKW – ARK Next Generation Internet ETF, ARKQ – ARK Autonomous Technology & Robotics ETF, BlackRock Inc., State Street Corp, Susquehanna International Group, Llp, PRNT – The 3D Printing ETF, KOMP – SPDR S&P Kensho New Economies Composite ETF, Citadel Advisors …
Who are Bionano genomics competitors?
13 Competitors
BioNano Genomics’s competitors are BioDiscovery, Fluxion Biosciences, IRX Therapeutics, Hepregen, Genvault Corporation and more.
How does Bionano genomics make money?
Revenue is produced by either directly selling the data to outsiders or by leveraging it for internal reasons, such as increasing the efficacy of advertising.
How many employees does BNGO have?
Compare BNGO With Other Stocks
| Bionano Genomics Annual Number of Employees | |
|---|---|
| 2020 | 147 |
| 2019 | 97 |
| 2018 | 77 |
| 2017 | 65 |
How much cash does BNGO have?
Bionano Genomics cash on hand from 2017 to 2021.
…
Compare BNGO With Other Stocks.
| Bionano Genomics Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2020 | $38 |
| 2019 | $17 |
| 2018 | $17 |
| 2017 | $1 |
Is BNGO in Russell?
(Nasdaq: BNGO) announced today that it was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on Monday, June 28, 2021, as part of the 2021 Russell indexes reconstitution.
What is the short interest on BNGO?
Bionano Genomics currently has a short interest ratio of 5.0.
When did BNGO IPO?
The units are scheduled to begin trading on The Nasdaq Capital Market under the ticker symbol “BNGOU” on August 21, 2018, and the offering is expected to close on August 23, 2018, subject to customary closing conditions.
Where is BNGO based?
The company was founded in 2003 and is headquartered in San Diego, California.
What sector is BNGO in?
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space.
Where is BNGO located?
The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Join TheMoney.co community and don’t forget to share this post !